The authors described that the levels of cathelicidin and β-defensin-2 in patients with basal cell carcinoma were significantly elevated and that the specificity of these AMPs in detecting of BCC was high (Fijałkowska et al. 2021a). This evidence concerns the gene ADSL and basal cell carcinoma.